Available Now!

A rapid immunoassay for the simultaneous detection and differential diagnosis of SARS-CoV-2, Influenza Type A and Type B antigen 

• Sensitivity and Specificity:
     − COVID-19 - Sensitivity 93.9%, Specificity 100%
     − Flu A - Sensitivity 91.4%, Specificity 95.7%
     − Flu B - Sensitivity 87.6%, Specificity 95.9%
• FDA Emergency Use Authorization (EUA)
• Results in 15 minutes!
• Flocked nasopharyngeal swabs improving specimen collection and ease of use

CPT CODES:

COVID-19: 87811

FLU A: 87804-QW

FLU B: 87804-QW-59